Before being forced out, Bed Bath & Beyond’s co-founders turned thrift, savvy merchandising & good timing into a co… https://t.co/qaPP1eJhQa— 15 hours 8 min ago via@theofrancis
@footnoted Oh wow. So glad you're all OK. What a nightmare.— 4 days 14 hours ago via@theofrancis
Striking story on due-diligence gone wrong, from Ron Liber of the New York Times: How Charlie Javice Got JPMorgan t… https://t.co/j2ivsbjpPI— 4 days 14 hours ago via@theofrancis
Unemployed Americans are spending more time out of work as employers slow hiring from a red-hot pace earlier in the… https://t.co/Iju8YFFNhn— 6 days 16 hours ago via@theofrancis
Crypto is back — in Davos, at least, along with Anthony Scaramucci — as redemption tour rolls on. Fun piece from Wa… https://t.co/l97mx4NtWd— 1 week 2 days ago via@theofrancis
With nudges and phone calls, analysts are urged to lower their estimates, making it easier for companies to beat them; ‘a rigged race,’ says Barry Diller
Just how busy are Washington lobbyists these days? Consider this: There are nearly 1,000 fewer of them than there were at this time last year—but their clients are spending just as feverishly as they did a year ago, shelling out $1.6 billion through June 30 alone.
Last year, John R. Stafford, chairman of pharmaceutical giant Wyeth, earned $1.8 million in salary. He also was awarded a $1.97 million bonus, restricted stock valued at $724,283 and 630,000 stock options.
That much shareholders can learn from glancing at the company's proxy.